Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Dr Pawan Saharan

Vice President of Global Business Development @Zydus Cadilla

Mumbai Metropolitan Region
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Present

Vice President of Global Business Development @Zydus Cadilla

Formed 10 JVs, research, tech-transfers and tie-ups with global MNCs.

EDUCATION

N/A

Stanford University Medical Center, California

Medical micro

1983 — 1987

West Virginia University

Doctor of Philosophy (Ph.D.), Medicine

1981 — 1983

Jawaharlal Nehru Technological University

MS, Life Sciences

N/A

Jawaharlal Nehru University (JNU)

Master of Science - MS, Life sciences & Biotechnology

SKILLS

Business DevelopmentNanotechnologyBiotechnologyMedicineDrug DiscoveryProtein PurificationFiltrationInfectious DiseasesStrategyLaboratoryLife SciencesBusiness StrategyStrategic PlanningTechnology TransferMarket Research

ABOUT DR PAWAN SAHARAN

EXECUTIVE SUMMARY OVERVIEW Our goal is to help billions of people worldwide via safe, affordable & effective treatment & prevention of all communicable diseases such as Wuhan Virus Covid-19 pandemic. Our clinically proven, broad spectrum, anti-viral immunomodulator is globally tested with 100% efficacy & safety for 12 years on 25000+ humans. The product consists of a patented new molecule of submicroscopic nonapeptides which have been isolated from bovine colostrum via patented Ultra Nano filtration Technology for first time. Our Vision: What causes illness and how to reach solutions in providing healthcare in every nook and corner of the universe via our Immunity Product, proprietary telemedicine & Lab on Chip for mass screening with emergency health alerts. STRATEGY Bringing the Product to the Markets in North America, Middle Est and Asia to begin with and export to UK, EU, RUSSIA, AUS from these counties with a differentiator from other COVID treatments/vaccines offered by GiLead, Pfizer, Moderna, Oxford Astra Zeneca, Sputnik & India under temporary FDA approvals which can be withdrawn. MARKET PROBLEMS Global pandemics like Wuhan COVID-19, Bird Flu, Swine Flu, HIV & chronic immunity disorders. People with weak immunity are at higher risk of getting severely sick from Covid-19. SOLUTION Our product made from mother’s 1st milk /bovine colostrum has nano informational peptides that help people lead longer & healthier lives by naturally building the body’s own immune system, aiding in prevention & cure of all communicable & immunity diseases along with sustainable malnutrition eradication for bottom of the pyramid segment globally. OPPORTUNITY We propose to use 21st Century Nanotechnology Innovation in improving health and wellbeing of 8 billion people by marketing & distribution of 8 different formulations viz. oral gargle, MMS, powder & liquid sachets. Opportunity for family funds via legacy projects, 10% quarterly dividends or 15% preferred shareholding along with exit via Nasdaq, LSE & Bombay Stock Exchange listings. Published Ref: https://patents.google.com/patent/US92•••88B2/en. http://medicaltraveltoday.com/spotlight-interview-pawan-saharan-founder-ceo-biomix-network-inc/ https://escientificpublishers.com/receptol-oral-spray-shield-for-coronavirus-proposed-treatment-prevention-as-demonstrated-in-aids-JBI-02-0007 Other products.. - Lab On Chip, a Diagnostics Product - Hospital On Chip, a Virtual Specialty Product

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.